Standout Papers

2014 ESC Guidelines on diagnosis and management of hypertrop... 2007 2026 2013 2019 2.9k
  1. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy (2014)
    Perry Elliott, Aris Anastasakis et al. European Heart Journal
  2. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2015)
    Silvia G. Priori, C. Blomström‐Lundqvist et al. European Heart Journal
  3. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases (2007)
    Perry Elliott, Eloisa Arbustini et al. European Heart Journal
  4. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2015)
    Silvia G. Priori, C. Blomström‐Lundqvist et al. EP Europace
  5. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD) (2013)
    Constantinos O’Mahony, Fatima Jichi et al. European Heart Journal
  6. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary (2020)
    Steve R. Ommen, Seema Mital et al. Journal of the American College of Cardiology
  7. Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis (2010)
    Andrew Flett, Martin Hayward et al. Circulation
  8. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients (2000)
    Perry Elliott, Jan Poloniecki et al. Journal of the American College of Cardiology
  9. Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy (2010)
    Rory O’Hanlon, Agata Grasso et al. Journal of the American College of Cardiology
  10. Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance (2003)
    James Moon, William J. McKenna et al. Journal of the American College of Cardiology
  11. How to develop a more accurate risk prediction model when there are few events (2015)
    Menelaos Pavlou, Gareth Ambler et al. BMJ
  12. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy (2020)
    Steve R. Ommen, Seema Mital et al. Journal of the American College of Cardiology
  13. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy (2020)
    Steve R. Ommen, Seema Mital et al. Circulation
  14. 2018 ESC Guidelines for the diagnosis and management of syncope (2018)
    Michele Brignole, Andrés Moyá et al. Kardiologia Polska
  15. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (2015)
    Silvia G. Priori, Carina Blomström‐Lundqvist et al. Kardiologia Polska
  16. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary (2020)
    Steve R. Ommen, Seema Mital et al. Circulation
  17. Cardiac Involvement in Fabry Disease (2021)
    Maurizio Pieroni, James Moon et al. Journal of the American College of Cardiology
  18. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial (2021)
    John A. Spertus, Jennifer Fine et al. The Lancet

Immediate Impact

6 from Science/Nature 192 standout
Sub-graph 1 of 13

Citing Papers

Cardiac Amyloidosis Due to Transthyretin Protein
2024 Standout
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches
2023 Standout
57 intermediate papers

Works of Perry Elliott being referenced

Contemporary and Future Approaches to Precision Medicine in Inherited Cardiomyopathies
2021
Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy
2020
and 53 more

Author Peers

Author Last Decade Papers Cites
Perry Elliott 28684 7028 5444 507 36.6k
Stephen E. Epstein 28307 7886 5983 523 45.6k
William J. McKenna 51710 11793 5349 696 58.3k
Douglas L. Mann 22373 11481 3597 442 38.1k
Jeffrey A. Towbin 35685 19344 5235 489 44.4k
Patrick T. Ellinor 25962 7042 2870 356 35.2k
Gerhard Schüler 24879 5240 6023 646 39.8k
Joshua M. Hare 12346 11023 1884 380 32.0k
Toyoaki Murohara 13705 17731 4402 1.2k 44.1k
Michael C. Fishbein 15692 7403 3236 635 36.5k
Richard Lee 9967 16620 2482 389 36.9k

All Works

Loading papers...

Rankless by CCL
2026